Details for New Drug Application (NDA): 211695
✉ Email this page to a colleague
The generic ingredient in ACETAMINOPHEN, ASPIRIN AND CAFFEINE is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.
Summary for 211695
Tradename: | ACETAMINOPHEN, ASPIRIN AND CAFFEINE |
Applicant: | Aurobindo Pharma Ltd |
Ingredient: | acetaminophen; aspirin; caffeine |
Patents: | 0 |
Pharmacology for NDA: 211695
Mechanism of Action | Cyclooxygenase Inhibitors |
Physiological Effect | Central Nervous System Stimulation Decreased Platelet Aggregation Decreased Prostaglandin Production |
Suppliers and Packaging for NDA: 211695
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACETAMINOPHEN, ASPIRIN AND CAFFEINE | acetaminophen; aspirin; caffeine | TABLET;ORAL | 211695 | ANDA | Better Living Brands, LLC | 21130-074 | 21130-074-07 | 1 BOTTLE in 1 CARTON (21130-074-07) / 24 TABLET, FILM COATED in 1 BOTTLE |
ACETAMINOPHEN, ASPIRIN AND CAFFEINE | acetaminophen; aspirin; caffeine | TABLET;ORAL | 211695 | ANDA | Better Living Brands, LLC | 21130-074 | 21130-074-14 | 1 BOTTLE in 1 CARTON (21130-074-14) / 50 TABLET, FILM COATED in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 250MG;250MG;65MG | ||||
Approval Date: | Feb 2, 2022 | TE: | RLD: | No |
Complete Access Available with Subscription